While tau pathology is clearly related to AD, it is well-established that pathological tau processing occurs in several different forms of dementia, and hence further studies in other dementias as well as cognitively normal elderly are needed to further characterize the potential of this marker. The gene discussed is MAPT; the disease is dementia.